Also, a recent study showed downregulated Nrf2 expression in a mouse prostate cancer model, and mechanistic studies identified a CpG island in the Nrf2 promoter region in tumorigenic TRAMP C1 cells but not in normal prostate or non-tumorigenic TRAMP C3 cells. This evidence concerns the gene NFE2L2 and Familial prostate cancer.